Table 1.
Relationship between LOX expression and clinicopathological characteristics of NSCLC patients
| Characteristics | Total cases(n = 110) | LOX protein | P value | |
|---|---|---|---|---|
|
|
||||
| + | - | |||
| Age | ||||
| ≤65 | 86 | 56 | 30 | 0.327 |
| >65 | 24 | 13 | 11 | |
| Gender | ||||
| Male | 75 | 47 | 28 | 0.985 |
| Female | 35 | 22 | 13 | |
| Pathological type | ||||
| Squamous | 41 | 26 | 15 | 0.909 |
| Adenocarcinoma | 69 | 43 | 26 | |
| Differentiation | ||||
| Well | 37 | 23 | 14 | 0.930 |
| Moderate + Poor | 73 | 46 | 27 | |
| Tumor size (cm) | ||||
| ≤3 | 42 | 20 | 22 | 0.010 |
| >3 | 68 | 49 | 19 | |
| Lymph node involvement | ||||
| No | 48 | 24 | 24 | 0.015 |
| Yes | 62 | 45 | 17 | |
| TNM stage | ||||
| I | 25 | 8 | 17 | 0.001 |
| II | 44 | 32 | 12 | |
| III | 41 | 29 | 12 | |